CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise President and CEO acquired 15,000 shares (option exercise)
- 4 Option exercise SVP, Chief Technology Officer acquired 5,197 shares (option exercise)
- 4 Option exercise SVP, General Counsel acquired 10,000 shares (option exercise)
- 4 Option exercise SVP, Chief Technology Officer acquired 15,773 shares (option exercise)
- 4 Open-market buy 10% owner bought 50,000 shares at $10.00 ($500,000)
- 4 Open-market buy Director bought 250,000 shares at $10.00 ($2,500,000)
- 4 Open-market buy SVP, General Counsel bought 250,000 shares at $10.00 ($2,500,000)
- 3/A Insider 3/A
- 4 Open-market buy 10% owner bought 750,000 shares at an average $10.00 ($7,500,000)
Page 9 of 10 · 197 filings